1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with promega in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (promega) | Trials (promega) | Recent Studies (post-2010) (promega) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 123 | 47 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilton, FH; Fonteh, AN; Hubbard, WC; Patel, M; Triggiani, M | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and promega
| Article | Year |
|---|---|
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage.
Topics: Adult; Dietary Fats; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Fish Oils; Humans; Kinetics; Leukotriene B4; Lipids; Male; Neutrophils; Phospholipids; Platelet Activating Factor; Reference Values; Time Factors | 1993 |